Bioatla Inc Stock Performance
as on March 28, 2026 at 6:59 am IST
Day's High
$0.15$0.1713.33%
Upside

52 Week's Low
52 Week's High
$0.13$1.43
13.33%
Downside
853.33%
Upside

Bioatla Inc share price movements today
- Previous Close
- $0.17
- Open
- $0.16
- Volume
- 1.7M
- Day's Low - High
- $0.15 - $0.17
- 52 Week Low - High
- $0.13 - $1.43
Bioatla Inc Historical Returns
- 1 Month Return
- -38.08 %
- 3 Month Return
- -81.65 %
- 1 Year Return
- -58.96 %
- 3 Year Return
- -93.48 %
- 5 Year Return
- -99.73 %
Bioatla Inc Stock Fundamentals & Key Indicators
Check Bioatla Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.1M
EPS (TTM)
-1.3767
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-65.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-813.88%
Bioatla Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bioatla Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $14.1M | -99.73% | NA | 0.00% | |
| BUY | $43.5B | 132.92% | 140.84 | 8.45% | |
| BUY | $115.2B | 101.77% | 29.58 | 32.94% | |
| NA | $31.8B | NA | 112.58 | 5.37% | |
| BUY | $80.0B | 54.69% | 18.25 | 31.41% |
Stock Returns calculator for Bioatla Inc Stock including INR - Dollar returns
The Bioatla Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioatla Inc investment value today
Current value as on today
₹51,168
Returns
Returns from Bioatla Inc Stock
Dollar Returns*
₹10,628 (+10.63%)
Analyst Recommendation on Bioatla Inc Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Bioatla Inc. Average target price of $10
Bioatla Inc Share Price Target
Get share price movements and forecasts by analysts on Bioatla Inc.
What analysts predicted
98.5%UPSIDE
Target Price
$10
Current Price
$0.15
Analyzed by
11 Analysts
Target
$10.00
Bioatla Inc target price $10, a slight upside of 98.5% compared to current price of $0.15. According to 11 analysts rating.
Bioatla Inc Stock’s Investor Sentiment and Interest
Search interest for Bioatla Inc Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Bioatla Inc Quarterly Profit & Loss
All numbers in Millions USD
Bioatla Inc Annual Profit & Loss
All numbers in Millions USD
Bioatla Inc Quarterly Cash Flow
All numbers in Millions USD
Bioatla Inc Annual Cash Flow
All numbers in Millions USD
Insights on Bioatla Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.0% return, outperforming this stock by 155.9%
NO EFFECTAgainst Peers

In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 77.2%
NEGATIVE IMPACTPrice Dip

In the last 1 month, BCAB stock has moved down by -38.1%
About Bioatla Inc
| Organisation | Bioatla Inc |
| Headquarters | 11085 Torreyana Road, San Diego, CA, United States, 92121 |
| Industry | Healthcare |
| CEO | Dr. Jay M. Short Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Bioatla Inc
Name | Title |
|---|---|
Dr. Gerhard Frey Ph.D. | Senior Vice President of Technology Development |
Ms. Monica Sullivan | Senior Vice President of Intellectual Property & Contracts |
Ms. Sheri Lydick | Chief Commercial Officer |
Dr. Jay M. Short Ph.D. | Co-Founder, CEO & Chairman |
Dr. Eric L. Sievers M.D. | Chief Medical Officer |
Ms. Susie Melody | Senior Vice President of Human Resources |
Dr. Cathy Chang Ph.D. | Senior Vice President of Research & Development |
Mr. Christian J. Vasquez CPA | CFO & Chief Accounting Officer |
Lisa M. Pelton | Accounting Manager |
FAQs
What is Bioatla Inc share price today?
Bioatla Inc share price today is $0.15 as on at the close of the market. Bioatla Inc share today touched a day high of $0.17 and a low of $0.15.
What is the 52 week high and 52 week low for Bioatla Inc share?
Bioatla Inc share touched a 52 week high of $1.43 on and a 52 week low of $0.13 on . Bioatla Inc stock price today i.e. is closed at $0.15,which is 89.51% down from its 52 week high and 15.38% up from its 52 week low.
What is Bioatla Inc's market capitalisation today?
Bioatla Inc market capitalisation is $0.00T as on .
How to invest in Bioatla Inc Stock (BCAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bioatla Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioatla Inc Shares that will get you 10.0000 shares as per Bioatla Inc share price of $0.15 per share as on March 28, 2026 at 1:29 am IST.
What is the minimum amount required to buy Bioatla Inc Stock (BCAB) from India?
Indian investors can start investing in Bioatla Inc (BCAB) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Bioatla Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioatla Inc share’s latest price of $0.15 as on March 28, 2026 at 1:29 am IST, you will get 66.6667 shares of Bioatla Inc. Learn more about
fractional shares .
What are the returns that Bioatla Inc has given to Indian investors in the last 5 years?
Bioatla Inc stock has given -99.73% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?